| Product NDC: | 49884-322 |
| Proprietary Name: | Olanzapine |
| Non Proprietary Name: | olanzapine |
| Active Ingredient(s): | 15 mg/1 & nbsp; olanzapine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49884-322 |
| Labeler Name: | Par Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078109 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111024 |
| Package NDC: | 49884-322-55 |
| Package Description: | 3 BLISTER PACK in 1 CARTON (49884-322-55) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (49884-322-52) |
| NDC Code | 49884-322-55 |
| Proprietary Name | Olanzapine |
| Package Description | 3 BLISTER PACK in 1 CARTON (49884-322-55) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (49884-322-52) |
| Product NDC | 49884-322 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | olanzapine |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20111024 |
| Marketing Category Name | ANDA |
| Labeler Name | Par Pharmaceutical, Inc. |
| Substance Name | OLANZAPINE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |